Metabolic syndrome is a key determinant of coronary microvascular function in patients with stable coronary disease and optimal low-density lipoprotein cholesterol levels undergoing percutaneous coronary intervention
HEART（2009）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要